Efficacy and safety of Aflibercept for the treatment of inflammatory choroidal neovascularization: The ALINEA study.
Laurent KodjikianAmro AbukhashabahChristine FardeauRamin TadayoniAntoine BrézinStéphane DumasMichel WeberLorraine BernardOlivier LoriaEvelyne DecullierLaure HuotThibaud MathisPublished in: Acta ophthalmologica (2022)
Our study shows that aflibercept is clinically effective, both anatomically and functionally in the treatment of inflammatory CNV. Following the first injection, the PRN strategy appears sufficient for treating most choroidal neovessels.